Supernus Pharmaceuticals
SUPN
HK$251.36
Share price
-2.18%
Change (1 day)
-1.07%
Change (1 year)
Categories
Operating Margin for Supernus Pharmaceuticals (SUPN)
Operating Margin as of March 2025 (TTM): 14.78%
According to Supernus Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 14.78%. At the end of 2024 the company had an Operating Margin of 14.79%.
Operating Margin history for Supernus Pharmaceuticals from 2011 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | 14.79% | 3144.52% |
| 2023 | 0.46% | -94.99% |
| 2022 | 9.10% | -27.87% |
| 2021 | 12.62% | -61.05% |
| 2020 | 32.41% | -13.7% |
| 2019 | 37.55% | 9.54% |
| 2018 | 34.28% | 2.98% |
| 2017 | 33.29% | 42.1% |
| 2016 | 23.43% | 136.46% |
| 2015 | 9.91% | -189.19% |
| 2014 | -11.11% | -98.55% |
| 2013 | -767.73% | -75.45% |
| 2012 | -3,127.30% | -36.38% |
| 2011 | -4,915.32% | -86.8% |
| 2010 | -37,239.62% | -341403.21% |
| 2009 | 10.91% | -102.9% |
| 2008 | -376.67% | -7.69% |
| 2007 | -408.04% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | -259.55% | -1,856.10% | 🇺🇸 USA |
 | 53.48% | 261.84% | 🇺🇸 USA |
 | 28.15% | 90.46% | 🇺🇸 USA |
 | -17.34% | -217.32% | 🇺🇸 USA |
 | 16.71% | 13.06% | 🇺🇸 USA |
 | 18.78% | 27.06% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.